Form D · Private Equity Fund
MED IV SCSp
Luxembourg, N4 · CIK 0002140064
Offering snapshot reported Aug 14, 2026 · SEC filing
- Reported sold
- $1.3B Indefinite offering
- Investors reported
- 179 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 3, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Aug 14, 2026 | Initial | $1,297,932,676 | No comparison | 179 | SEC filing |
Offering details
- Securities
- Pooled investment fund
- Exemptions
- 06c, 3C, 3C.7
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-594369
Amount is based on the currency conversion rate of 1 EUR = 1.1435 USD.
Source: Form D, filed Aug 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| N/A Archimed Sas | Executive |
| Jaime Rincon Gomez Ferrer | Director |
| Jeppe Lindgaard | Director |
| N/A Med Iv Gp S.A R.L. | Executive |
| Javier Valls | Director |
Issuer details
Industry: Pooled Investment Fund (See others in industry)
Address:
5, Rue Jean Monnet
Luxembourg, N4, L-2180
Luxembourg, N4, L-2180